The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Abstract
A long-standing paradox in cellular immunology concerns the conditional requirement for CD4+ T-helper (T(H)) cells in the priming of cytotoxic CD8+ T lymphocyte (CTL) responses in vivo. Whereas CTL responses against certain viruses can be primed in the absence of CD4+ T cells, others, such as those mediated through 'cross-priming' by host antigen-presenting cells, are dependent on T(H) cells. A clearer understanding of the contribution of T(H) cells to CTL development has been hampered by the fact that most T(H)-independent responses have been demonstrated ex vivo as primary cytotoxic effectors, whereas T(H)-dependent responses generally require secondary in vitro re-stimulation for their detection. Here, we have monitored the primary and secondary responses of T(H)-dependent and T(H)-independent CTLs and find in both cases that CD4+ T cells are dispensable for primary expansion of CD8+ T cells and their differentiation into cytotoxic effectors. However, secondary CTL expansion (that is, a secondary response upon re-encounter with antigen) is wholly dependent on the presence of T(H) cells during, but not after, priming. Our results demonstrate that T-cell help is 'programmed' into CD8+ T cells during priming, conferring on these cells a hallmark of immune response memory: the capacity for functional expansion on re-encounter with antigen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter cell death is mediated by expression of the death ligand TRAIL, which triggers apoptosis in the helpless CTL as well as other activated T cells70,72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“In support of this, TRAIL-deficient mice were resistant to tolerance induction by intravenously injected apoptotic cells72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“As a result, the CD8+ T cells produce TRAIL upon re-exposure to antigen, which acts to inhibit immunization for cell-mediated responses (that is, mediate tolerance).”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“DC that have engulfed necrotic cells present antigen to both CD4+ and CD8+ T cells, however those that engulf apoptotic cells present antigen to CD8+ T cells but not CD4+ T cells72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
Citations
Cites
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
Self-citationA conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Rosa, F. D., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,360
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,091
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865
Immunological memory and protective immunity: understanding their relation
Ahmed, R., & Gray, D. (1996) · Science · doi:10.1126/science.272.5258.54 · Cited by 1,775 · cited 1×
“Although transition through these stages was thought to be governed by the presence and eventual elimination of antigen, mounting evidence suggests that CD8 p T-cell development is guided by an instructional programme that, once set into motion during priming, is executed independentl”
BackgroundDialynas, D. P., Quan, Z., Wall, K. A., Pierrès, A., Quintáns, J., Loken, M. R., Pierres, M., & Fitch, F. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.5.2445 · Cited by 1,273
Kaech, S. M., & Ahmed, R. (2001) · Nature Immunology · doi:10.1038/87720 · Cited by 1,265
van Stipdonk, M. J. B., Lemmens, E. E., & Schoenberger, S. P. (2001) · Nature Immunology · doi:10.1038/87730 · Cited by 843
Self-citationT Cell-Dependent B Cell Activation
Parker, D. C. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001555 · Cited by 739
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Unravelling the mechanisms of help for CD8+ T cell responses
Livingstone, A. M., Wilson, E. B., Ontiveros, F., & Wang, J.-C. E. (2009) · Immunologic Research · doi:10.1007/s12026-009-8102-0 · Cited by 22
Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination
Steitz, J., Tormo, D., Schweichel, D., & Tüting, T. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700894 · Cited by 21
Kamiryo, Y., Yajima, T., Saito, K., Nishimura, H., Fushimi, T., Ohshima, Y., Tsukamoto, Y., Naito, S., & Yoshikai, Y. (2005) · International Journal of Cancer · doi:10.1002/ijc.20934 · Cited by 21
Horne, P. H., Koester, M. A., Jayashankar, K., Lunsford, K. E., Dziema, H., & Bumgardner, G. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.80 · Cited by 23
Phenotype and Homing of CD4 Tumor-Specific T Cells Is Modulated by Tumor Bulk
Benigni, F., Zimmermann, V. S., Hugues, S., Caserta, S., Basso, V., Rivino, L., Ingulli, E. G., Malherbe, L. P., Glaichenhaus, N., & Mondino, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.739 · Cited by 21
Immunological pathogenesis and treatment progress of adenovirus pneumonia in children
Liang, Y., Wei, J., Shen, J., Liang, Z., Ma, X., Du, Y., Qian, W., Dong, H., Huang, P., Chen, A., et al. (2025) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-024-01836-1 · Cited by 20
Chen, J., Chen, J., & Wang, L. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200174 · Cited by 21
The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME)
DiPalma, M. P., & Blattman, J. N. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1141215 · Cited by 21
MDM2 inhibitors in cancer immunotherapy: Current status and perspective
Zeng, Q., Zeng, S., Dai, X., Ding, Y., Huang, C., Ruan, R., Xiong, J., Tang, X., & Deng, J. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101279 · Cited by 20
Chicken HSP70 DNA vaccine inhibits tumor growth in a canine cancer model
Yu, W.-Y., Chuang, T., Guichard, C., Garch, H. E., Tierny, D., Laio, A. T., Lin, C.-S., Chiou, K.-H., Tsai, C.-L., Ch, L., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.031 · Cited by 20
Targeting T-cell memory: where do we stand?
Valujskikh, A. (2008) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283061126 · Cited by 20
Li, L., Herndon, J. M., Truscott, S. M., Hansen, T. H., Fleming, T. P., Goedegebuure, P. S., & Gillanders, W. E. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.10.096 · Cited by 21
Ohkuri, T., Wakita, D., Chamoto, K., Togashi, Y., Kitamura, H., & Nishimura, T. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604966 · Cited by 20
Circulating Type-1 Anti-Tumor CD4+T Cells are Preferentially Pro-Apoptotic in Cancer Patients
Wesa, A. K., Mandić, M., Taylor, J. L., Moschos, S. J., Kirkwood, J. M., Kwok, W. W., Finke, J. H., & Storkus, W. J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00266 · Cited by 20
Andersen, A. N., Landsverk, O. J. B., Simonsen, A., Bogen, B., Corthay, A., & Øynebråten, I. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00167 · Cited by 22
Hayashi, R., Nagato, T., Kumai, T., Ohara, K., Ohara, M., Ohkuri, T., Hirata‐Nozaki, Y., Harabuchi, S., Kosaka, A., Nagata, M., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1856545 · Cited by 20
Umeshappa, C. S., Xie, Y., Xu, S., Nanjundappa, R. H., Freywald, A., Deng, Y., Ma, H., & Xiang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064787 · Cited by 20
Antigen-Specific CD4 Cells Assist CD8 T-Effector Cells in Eliminating Keratinocytes
Broom, J. K., Lew, A. M., Azukizawa, H., Kenna, T., Leggatt, G. R., & Frazer, I. H. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.17 · Cited by 20
Lichterfeld, M. D., Gandhi, R. T., Simmons, R. P., Flynn, T., Sbrolla, A., Yu, X. G., Basgoz, N. O., Mui, S. K., Williams, K. L., Streeck, H., et al. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182373b77 · Cited by 21
Dell, K., Koesters, R., & Gissmann, L. (2005) · International Journal of Cancer · doi:10.1002/ijc.21360 · Cited by 20
Mobilizing forces - CD4+ helper T cells script adaptive immunity
Masson, F., & Belz, G. T. (2010) · Cell Research · doi:10.1038/cr.2010.1 · Cited by 20
Koehler, J. W., Bolton, M. J., Rollins, A., Snook, K., Deharo, E., Henson, E. W., Rogers, L. B., Martin, L. N., Krogstad, D. J., James, M. A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007139 · Cited by 20
In vivo rescue of defective memory CD8+ T cells by cognate helper T cells
Kumaraguru, U., Banerjee, K., & Rouse, B. T. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0105007 · Cited by 21
Self-Antigen Prevents CD8 T Cell Effector Differentiation by CD134 and CD137 Dual Costimulation
Bandyopadhyay, S., Long, M., Qui, H. Z., Hagymasi, A. T., Slaiby, A. M., Mihalyo, M. A., Aguila, H. L., Mittler, R. S., Vella, A. T., & Adler, A. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7728 · Cited by 20
Hirayama, M., Tomita, Y., Yuno, A., Tsukamoto, H., Senju, S., Imamura, Y., Sayem, M. A., Irie, A., Yoshitake, Y., Fukuma, D., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1123368 · Cited by 20
Spontaneous CD4+ T Cell Responses against TRAG-3 in Patients with Melanoma and Breast Cancers
Janjic, B. M., Andrade, P., Wang, X., Fourcade, J. J., Almunia, C., Kudela, P., Brufsky, A., Jacobs, S. A., Friedland, D., Stoller, R. G., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2717 · Cited by 20
Dissection of cytotoxic and helper T cell responses
Schepers, K., Arens, R., & Schumacher, T. N. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5266-1 · Cited by 20
Zhang, Y., Qiu, J., Zhou, Y. J., Farhangfar, F., Hester, J. H., Lin, A. Y., & Decker, W. K. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.11.072 · Cited by 20
Lipinski, K. S., Pelech, S., Mountain, A., Irvine, A. S., Kraaij, R., Bangma, C. H., Mills, K. H. G., & Todryk, S. M. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0014-9 · Cited by 20
How DCs control cross-regulation between lymphocytes
Creusot, R. J., & Mitchison, N. A. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.01.005 · Cited by 20
Hackenbruch, C., Bauer, J., Heitmann, J. S., Maringer, Y., Nelde, A., Denk, M., Zieschang, L., Kammer, C., Federmann, B., Jung, S., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1367450 · Cited by 20
Novel biomanufacturing platform for large-scale and high-quality human T cells production
Ou, J., Si, Y., Tang, Y., Salzer, G., Lü, Y., Kim, S., Qin, H., Zhou, L., & Liu, M. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0167-2 · Cited by 19
Srivastava, M. K., Bosch, J. J., Wilson, A. L., Edelman, M. J., & Ostrand‐Rosenberg, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25462 · Cited by 19
Wolkers, M. C., Bensinger, S. J., Green, D. R., Schoenberger, S. P., & Janssen, E. M. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.04.011 · Cited by 21
Self-citationSarobe, P., Lasarte, J. J., García, N., Civeira, M. P., Borrás‐Cuesta, F., & Prìeto, J. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00653.x · Cited by 19
Rao, N., Qiu, J., Wu, J., Zeng, H., Su, F., Qiu, K., Wu, J., & Yao, H. (2017) · Chemotherapy · doi:10.1159/000470900 · Cited by 19
Takemoto, S., Nishikawa, M., Guan, X., Ohno, Y., Yata, T., & Takakura, Y. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1001069 · Cited by 19
Th-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens
Decker, W. K., Xing, D., Li, S., Robinson, S. N., Yang, H. Y., Steiner, D., Komanduri, K. V., & Shpall, E. J. (2009) · Blood · doi:10.1182/blood-2008-10-185470 · Cited by 19
Rice, J., Dossett, M. L., Öhlén, C., Buchan, S. L., Kendall, T. J., Dunn, S. N., Stevenson, F. K., & Greenberg, P. D. (2008) · European Journal of Immunology · doi:10.1002/eji.200838213 · Cited by 19
Castro, I., Dee, M. J., & Malek, T. R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202067 · Cited by 19
Miconnet, I., & Pantaleo, G. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.028 · Cited by 19
Differential effects of statins on relevant functions of human monocyte-derived dendritic cells
Tao, J., Segal, B. H., Eppolito, C., Li, Q., Dennis, C. G., Youn, R. C., & Shrikant, P. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0106026 · Cited by 19
Yuan, J. D., Latouche, J., Reagan, J. L., Heller, G., Rivière, I., Sadelain, M., & Young, J. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.758 · Cited by 19
Highly Efficient Antiviral CD8+T-Cell Induction by Peptides Coupled to the Surfaces of Liposomes
Takagi, A., Matsui, M., Ohno, S., Duan, H., Moriya, O., Kobayashi, N., Oda, H., Mori, M., Kobayashi, A., Taneichi, M., et al. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00116-09 · Cited by 19
Duration of CTL activation regulates IL‐2 production required for autonomous clonal expansion
Spierings, D. C. J., Lemmens, E. E., Grewal, K., Schoenberger, S. P., & Green, D. R. (2006) · European Journal of Immunology · doi:10.1002/eji.200635929 · Cited by 20
Self-citationAmara, R. R., Sharma, S., Patel, M., Smith, J. M., Chennareddi, L. S., Herndon, J. G., & Robinson, H. L. (2005) · Virology · doi:10.1016/j.virol.2005.01.026 · Cited by 19
Witkowski, M., Spangenberg, H. C., Neumann‐Haefelin, C., Büttner, N., Breous, E., Kersting, N., Drognitz, O., Hopt, U. T., Blum, H. E., Semmo, N., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25866 · Cited by 20
Arina, A., Karrison, T., Galka, E., Schreiber, K., Weichselbaum, R. R., & Schreiber, H. W. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0293 · Cited by 18
CD40 ligand stimulation affects the number and memory phenotypes of human peripheral CD8+ T cells
Choi, H., Lee, H.-J., Sohn, H., & Kim, T. (2023) · BMC Immunology · doi:10.1186/s12865-023-00547-2 · Cited by 18
Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota
Wen, M., Li, Y., Qin, X., Qin, B., & Wang, Q. A. (2023) · Cells · doi:10.3390/cells12141882 · Cited by 20
Palmeri, J. R., Lax, B. M., Peters, J. M., Duhamel, L., Stinson, J. A., Santollani, L., Lutz, E. A., Pinney, W., Bryson, B. D., & Wittrup, K. D. (2024) · Nature Communications · doi:10.1038/s41467-024-45625-0 · Cited by 18
Targets for the Induction of Protective Immunity Against Influenza A Viruses
Bodewes, R., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2010) · Viruses · doi:10.3390/v2010166 · Cited by 18
Liposome-Coupled Peptides Induce Long-Lived Memory CD8+ T Cells Without CD4+ T Cells
Taneichi, M., Tanaka, Y., Kakiuchi, T., & Uchida, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015091 · Cited by 18
Kremer, A. N., van der Griendt, J. C., van der Meijden, E. D., Honders, M. W., Ayoglu, B., Schwenk, J. M., Nilsson, P., Falkenburg, J. H. F., & Griffioen, M. (2013) · Haematologica · doi:10.3324/haematol.2013.086652 · Cited by 18
Cornel, A. M., van Til, N. P., Boelens, J. J., & Nierkens, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00982 · Cited by 18
Zhuang, X., Shi, G., Hu, X., Wang, H., Sun, W., & Wu, Y. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001558 · Cited by 18
Tveita, A. A., Schjesvold, F. H., Sundnes, O., Haabeth, O. A. W., Haraldsen, G., & Bogen, B. (2014) · European Journal of Immunology · doi:10.1002/eji.201444659 · Cited by 19
Rapid MHC-II Antigen Presentation of HIV Type 1 by Human Dendritic Cells
Jones, L., McDonald, D. J., & Canaday, D. H. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.0280 · Cited by 18
Saha, A., Chatterjee, S. K., Foon, K. A., & Bhattacharya‐Chatterjee, M. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02391.x · Cited by 18
Kotturi, M. F., Botten, J., Maybeno, M., Sidney, J., Glenn, J., Bui, H., Oseroff, C., Crotty, S., Peters, B., Grey, H. M., et al. (2010) · Immunome Research · doi:10.1186/1745-7580-6-4 · Cited by 18
Iurescia, S., Fioretti, D., Pierimarchi, P., Signori, E., Zonfrillo, M., Tonon, G., Fazio, V. M., & Rinaldi, M. (2010) · BioMed Research International · doi:10.1155/2010/316069 · Cited by 18
Induction of CD4-Independent E7-Specific CD8 + Memory Response by Heat Shock Fusion Protein
Liu, H., Wu, B. H., Rowse, G. J., & Emtage, P. C. R. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00029-07 · Cited by 18
Montfort, M. J., Bouwer, H. G. A., Wagner, C. R., & Hinrichs, D. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4084 · Cited by 18
Ma, C. K. K., Clancy, L. E., Deo, S. S., Blyth, E., Micklethwaite, K. P., & Gottlieb, D. J. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.09.013 · Cited by 18
Development of an AIDS vaccine using Sendai virus vectors
Ishii, H., & Matano, T. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.114 · Cited by 18
Franco, A. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2005.01596.x · Cited by 18
Burton, C., Gotch, F. M., & Imami, N. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.11.005 · Cited by 18
Peng, Y., Shao, H., Yan, K., Zhang, P., Xiang, J., Kaplan, H. J., & Sun, D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.5006 · Cited by 18
The Promised Land of Human ImmunologyPreprint
Su, L. F., Han, A. S., McGuire, H. M., Furman, D., Newell, E. W., & Davis, M. M. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.022905 · Cited by 18
Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials
Akbari, E., Seyedinkhorasani, M., & Bolhassani, A. (2023) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2023.102774 · Cited by 17
Osen, W., Soltek, S., Song, M., Leuchs, B., Steitz, J., Tüting, T., Eichmüller, S. B., Nguyen, X. D., Schadendorf, D., & Paschen, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014137 · Cited by 20
Ekkirala, C. R., Cappello, P., Accolla, R. S., Giovarelli, M., Romero, I., Garrido, C., Garcia-Lora, A. M., & Novelli, F. (2014) · Pancreas · doi:10.1097/mpa.0000000000000160 · Cited by 17
Myc, L. A., Gamian, A., & Myc, A. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0129-y · Cited by 17
Vaccination With OK-432 Followed by TC-1 Tumor Lysate Leads to Significant Antitumor Effects
Chen, I.-J., Yen, C., Lin, K., Lee, C., Soong, Y., Lai, C., & Lin, C. (2011) · Reproductive Sciences · doi:10.1177/1933719110396230 · Cited by 17
Umeshappa, C. S., Nanjundappa, R. H., Xie, Y., Freywald, A., Deng, Y., Ma, H., & Xiang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047004 · Cited by 19
The TRAIL of Helpless CD8 + T Cells in HIV Infection
Küerten, S., Asaad, R. J., Schoenberger, S. P., Angelov, D. N., Lehmann, P., & Tary‐Lehmann, M. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0062 · Cited by 17
Self-citationAndrews, N. P., Pack, C. D., Vezys, V., Barber, G. N., & Lukacher, A. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7267 · Cited by 17
Cui, Z., & Qiu, F. (2007) · Journal of Immunotherapy · doi:10.1097/01.cji.0000211330.61019.6f · Cited by 17
Heterogeneous expansion of CD4+ tumor-infiltrating T-lymphocytes in clear cell renal cell carcinomas
Zhang, Q., Jia, Q., Deng, T., Song, B., & Li, L. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.069 · Cited by 17
Xie, Y., Chen, Y., Ahmed, K. A., Li, W., Ahmed, S., Sami, A., Chibbar, R., Tang, X., Tao, M., Xu, J., et al. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2013.60 · Cited by 19
Yokomine, K., Nakatsura, T., Senju, S., Nakagata, N., Minohara, M., Kira, J., Motomura, Y., Kubo, T., Sasaki, Y., & Nishimura, Y. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00612.x · Cited by 17
Tetherin/BST-2: Restriction Factor or Immunomodulator?
Li, S. X., Barrett, B. S., Guo, K., & Santiago, M. L. (2016) · Current HIV Research · doi:10.2174/1570162x14999160224102752 · Cited by 17
Class II MHC/Peptide Interaction in Leishmania donovani Infection: Implications in Vaccine Design
Roy, K., Naskar, K., Ghosh, M., & Roy, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302970 · Cited by 17
Peng, B., Voltan, R., Cristillo, A. D., Alvord, W. G., Davis‐Warren, A., Zhou, Q., Murthy, K. K., & Robert-Guroff, M. (2006) · AIDS · doi:10.1097/qad.0b013e32801086ee · Cited by 17
Zheng, N. N., McElrath, M. J., Sow, P. S., Hawes, S. E., Agne, H. D., Stern, J., Li, F., Mesher, A. L., Robinson, A. D., Gottlieb, G. S., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00117-07 · Cited by 17
Pajot, A. (2004) · International Immunology · doi:10.1093/intimm/dxh129 · Cited by 17
Paschen, A., Song, M., Osen, W., Nguyen, X. D., Mueller-Berghaus, J., Fink, D., Daniel, N., Donzeau, M., Nagel, W., Kropshofer, H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0170 · Cited by 17
Memory T Cells in Rhesus Macaques
Vaccari, M., & Franchini, G. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6451-9_10 · Cited by 17
Adoptive Therapy with T Cells/NK Cells
Cooley, S., June, C. H., Schoenberger, S. P., & Miller, J. S. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.10.008 · Cited by 17
Self-citationDefective IL-2 Production by HIV-1-Specific CD4 and CD8 T Cells in an Adolescent/Young Adult Cohort
Kapogiannis, B. G., Henderson, S. L., Nigam, P., Sharma, S., Chennareddi, L. S., Herndon, J. G., Robinson, H. L., & Amara, R. R. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.272 · Cited by 17
Wang, X. Z., Brehm, M. A., & Welsh, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5138 · Cited by 17
Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy
Kast, W. M., Levitsky, H. I., & Marincola, F. M. (2004) · Journal of Translational Medicine · doi:10.1186/1479-5876-2-20 · Cited by 17
Driessens, G., Hamdane, M., Cool, V., Velu, T. J., & Bruyns, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0774 · Cited by 17
Roerden, M., Märklin, M., Salih, H. R., Bethge, W. A., Klein, R., Rammensee, H., Nelde, A., & Walz, J. S. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1885659 · Cited by 17
Targeting NKG2D/NKG2DL axis in multiple myeloma therapy
Liu, Z., Wang, H., Liu, H., Ding, K., Shen, H., Zhao, X., & Fu, R. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.02.001 · Cited by 16
Hennies, C. M., Reboulet, R. A., Garcia, Z., Nierkens, S., Wolkers, M. C., & Janssen, E. M. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04305.x · Cited by 16
Self-citationIdentification of a Human Cyclin D1-Derived Peptide that Induces Human Cytotoxic CD4 T Cells
Dao, T., Korontsvit, T., Zakhaleva, V., Haro, K. J., Packin, J., & Scheinberg, D. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006730 · Cited by 16
Holland, M. J., Faal, N., Sarr, I., Joof, H., Laye, M., Cameron, E., Pemberton-Pigott, F., Dockrell, H. M., Bailey, R. L., & Mabey, D. C. W. (2006) · Infection and Immunity · doi:10.1128/iai.74.3.1565-1572.2006 · Cited by 16
Chauchet, X., Hannani, D., Djebali, S., Laurin, D., Polack, B., Marvel, J., Buffat, L., Toussaint, B., & Gouëllec, A. L. (2016) · Molecular Therapy — Oncolytics · doi:10.1038/mto.2016.33 · Cited by 16
Rahman, M. A., McKinnon, K. M., Karpova, T., Ball, D. A., Venzon, D. J., Fan, W., Kang, G., Li, Q., & Robert-Guroff, M. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701403 · Cited by 16
Metadata
- Authors
- Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., & Schoenberger, S. P.
- Affiliations
- La Jolla Institute for Immunology (US)
- Corresponding author
- Schoenberger, Stephen P.
- Venue
- Nature
- Published
- 2003-02
- Volume
- 421
- Issue
- 6925
- Pages
- 852-856
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1493822493
- Cited by
- 1,635
- References
- 28
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 37 · 2023: 46 · 2022: 37 · 2021: 42 · 2020: 58 · 2019: 42 · 2018: 52 · 2017: 36 · 2016: 41 · 2015: 61 · 2014: 63 · 2013: 63 · 2012: 71
- FWCI
- 46.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- CD4+ T cells, CD8+ T cells, cytotoxic T lymphocytes, T helper cells, secondary immune response, T cell memory, T cell help, cross-priming, antigen-presenting cells, T cell differentiation
- MeSH terms
- Animals, Antigens, Cell Line, Cytotoxicity, Immunologic, Flow Cytometry, T-Lymphocytes, Helper-Inducer, Immunologic Memory, Lymphocyte Activation, Lymphocytic choriomeningitis virus, T-Lymphocytes, Cytotoxic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review